European guideline for the management of donovanosis, 2010

International Journal of STD and AIDS

Volumn 21, Issue 9, 2010, Pages 609-610

  O'Farrell, Nigel ^a   Moi, H ^b,c  

^a EALING HOSPITAL   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Calymmatobacterium granulomatis; Donovanosis; Genital ulcer disease; Granuloma inguinale

Indexed keywords

AZITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN;

CALYMMATOBACTERIUM GRANULOMATIS; EUROPE; GENITAL ULCER; GRANULOMA INGUINALE; INCUBATION TIME; KLEBSIELLA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CALYMMATOBACTERIUM; EUROPE; GRANULOMA INGUINALE; HISTOCYTOCHEMISTRY; MICROSCOPY; POLYMERASE CHAIN REACTION;

EID: 78649369572     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010245     Document Type: Short Survey

References (18)

1. Carter J, Bowden FJ, Bastian I, et al. Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb nov. Int J Syst Bacteriol 1999;49:1695-700 (Pubitemid 29519100)
2. Kharsany AB, Hoosen AA, Kiepala P, et al. Phylogenetic analysis of Calymmatobacterium granulomatis based on 16S sequences. J Med Microbiol 1999;48:841-7
3. Bowden FJ. Donovanosis in Australia: going, going. . . Sex Trans Inf 2005;81:365-6
4. Rajam RV, Rangiah PN. Donovanosis. Monograph series no 24, WHO, Geneva, 1954
5. O'Farrell N, Windsor I, Becker P. Risk factors for HIV-1 in heterosexual attenders at a sexually transmitted diseases clinic in Durban. S Afr Med J 1991;80:17-20
6. O'Farrell N. A rapid staining technique for the diagnosis of granuloma inguinale (donovanosis). Genitourin Med 1990;66:200-1
7. Velho PE, de Souza EM, Belda W. Donovanosis. Braz J Infect Dis 2008;12:521-5
8. Kharsany AB, Hoosen AA, Kiepala P, et al. Growth and cultural characteristics of Calymmatobacterium granulomatis: the aetiological agent of granuloma inguinale (donovanosis). J Med Microbiol 1997;46:579-85
9. Carter J, Hutton S, Sriprakash KS, et al. Culture of the causative organism for donovanosis (Calymmatobacterium granulomatis) in Hep-2 cells. J Clin Microbiol 1997;35:2915-17 (Pubitemid 27452434)
10. Bastian I, Bowden FJ. Amplification of Klebsiella-like sequences from biopsy samples from patients with donovanosis. Clin Infect Dis 1996;23:1328-30 (Pubitemid 26423186)
11. Carter JS, Kemp DJ. A colorimetric detection system for Calymmatobacterium granulomatis. Sex Transm Inf 2000;76:134-6
12. Mackay IM, Harnett G, Jeoffreys N, et al. Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clin Infect Dis 2006;42:1431-8
13. Bowden FJ, Mein J, Plunkett C, Bastian I. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med 1994;72:17-19
14. Lal S, Garg BR. Further evidence of the efficacy of co-trimoxazole in donovanosis. Br J Vener Dis 1980;56:412-13 (Pubitemid 11161287)
15. Greenblatt RB, Barfield WE, Dienst RB, et al. Terramycin in the treatment of granuloma inguinale. J Vener Dis Inf 1951;32:113-15
16. Robinson HM, Cohen MM. Treatment of granuloma inguinale with erythromycin. J Invest Dermatol 1953;20:407-19
17. Maddocks I, Anders EM, Dennis E. Donovanosis in Papua New Guinea. Br J Vener Dis 1976;52:190-6
18. Bowden FJ, Bright A, Rode JW, Brewster D. Donovanosis causing cervical lymphadenopathy in a five-month old boy. Paed Infect Dis J 2000;19:167-9 (Pubitemid 30111419)